As in our preclinical model, the heterogeneous population containing all CD8+ T cells did not correlate with disease-free survival, strongly supporting the notion that CD39+PD-1+CD8+ T cells comprise a population of cells that is uniquely equipped to control disseminated cancer cells. The gene discussed is CD8A; the disease is cancer.